{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:55:06Z","timestamp":1774623306382,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nanjing Health Science and Technology Development Major Project","award":["ZDX22001"],"award-info":[{"award-number":["ZDX22001"]}]},{"name":"Nanjing Drum Tower Hospital Special Funds Program","award":["RC2023-033"],"award-info":[{"award-number":["RC2023-033"]}]},{"name":"Top Talent Support Program for Young and Middle-Aged People of Wuxi Health Committee","award":["HB2023116"],"award-info":[{"award-number":["HB2023116"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82103135"],"award-info":[{"award-number":["82103135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04726-6","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T20:22:24Z","timestamp":1771705344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The inflammatory state of tumor peripheral liver tissue affects hepatocellular carcinoma progression and prognosis"],"prefix":"10.1007","volume":"17","author":[{"given":"Chunlong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuya","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaobo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"issue":"5","key":"4726_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, D\u2019Angelica MI, Abbott DE, Anaya DA, Anders R, Are C, et al. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(5):541\u201365.","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"4726_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","volume":"29","author":"R Nevola","year":"2023","unstructured":"Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, et al. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol. 2023;29(8):1243\u201360.","journal-title":"World J Gastroenterol"},{"issue":"20","key":"4726_CR3","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.3390\/cancers13205180","volume":"13","author":"S Krishnamurthy","year":"2021","unstructured":"Krishnamurthy S, Gilot D, Ahn SB, Lam V, Shin JS, Guillemin GJ, et al. Involvement of Kynurenine Pathway in Hepatocellular Carcinoma. Cancers (Basel). 2021;13(20):5180.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"4726_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/annonc\/mdz103","volume":"30","author":"LX Xu","year":"2019","unstructured":"Xu LX, He MH, Dai ZH, Yu J, Wang JG, Li XC, et al. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma. Ann Oncol. 2019;30(6):990\u20137.","journal-title":"Ann Oncol"},{"issue":"3","key":"4726_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.hbpd.2019.03.012","volume":"18","author":"JX Mao","year":"2019","unstructured":"Mao JX, Teng F, Liu C, Yuan H, Dong JY, Fu H, Ding GS, Guo WY. Immunometabolic inflammation and hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2019;18(3):298\u2013300.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"5","key":"4726_CR6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","volume":"164","author":"MR Toh","year":"2023","unstructured":"Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PK, et al. Global epidemiology and genetics of hepatocellular carcinoma. Gastroenterology. 2023;164(5):766\u201382.","journal-title":"Gastroenterology"},{"issue":"1","key":"4726_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0038-1676806","volume":"39","author":"YM Yang","year":"2019","unstructured":"Yang YM, Kim SY, Seki E. Inflammation and Liver cancer: molecular mechanisms and therapeutic targets. Semin Liver Dis. 2019;39(1):26\u201342.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"4726_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","volume":"17","author":"KY Shen","year":"2024","unstructured":"Shen KY, Zhu Y, Xie SZ, Qin LX. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J Hematol Oncol. 2024;17(1):25.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"4726_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372\u20134.","journal-title":"J Hepatol"},{"issue":"4","key":"4726_CR10","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399.","journal-title":"Hepatology"},{"issue":"1","key":"4726_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s12879-023-08632-y","volume":"23","author":"YN Dai","year":"2023","unstructured":"Dai YN, Xu CF, Pan HY, Chen MJ, Yu CH. Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection. BMC Infect Dis. 2023;23(1):637.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"4726_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00261-024-04543-x","volume":"50","author":"W Ding","year":"2025","unstructured":"Ding W, Bi M, Gao Y, Zheng L, Chen J, Liu F, et al. The influence of peritumoral parenchyma on local tumor progression of hepatocellular carcinoma after thermal ablation: a retrospective multicenter study. Abdom Radiol (NY). 2025;50(2):710\u20139.","journal-title":"Abdom Radiol (NY)"},{"issue":"6","key":"4726_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ccell.2019.04.007","volume":"35","author":"R Xue","year":"2019","unstructured":"Xue R, Chen L, Zhang C, Fujita M, Li R, Yan SM, et al. Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes. Cancer Cell. 2019;35(6):932\u2013e9478.","journal-title":"Cancer Cell"},{"key":"4726_CR14","doi-asserted-by":"publisher","first-page":"e15950","DOI":"10.7717\/peerj.15950","volume":"11","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Chen C, Sun M, Xu X, Liu Y, Liu Q, et al. A decision tree model to predict liver cirrhosis in hepatocellular carcinoma patients: a retrospective study. PeerJ. 2023;11:e15950.","journal-title":"PeerJ"},{"issue":"4","key":"4726_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/hep4.1859","volume":"6","author":"J Liu","year":"2022","unstructured":"Liu J, Wang J, Yan X, Xue R, Zhan J, Jiang S, et al. Presence of liver inflammation in asian patients with chronic hepatitis B with normal ALT and detectable HBV DNA in absence of liver fibrosis. Hepatol Commun. 2022;6(4):855\u201366.","journal-title":"Hepatol Commun"},{"issue":"11","key":"4726_CR16","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1111\/cas.14641","volume":"111","author":"SK Qin","year":"2020","unstructured":"Qin SK, Li Q, Ming Xu J, Liang J, Cheng Y, Fan Y, et al. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival. Cancer Sci. 2020;111(11):4218\u201331.","journal-title":"Cancer Sci"},{"issue":"6","key":"4726_CR17","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.jhep.2020.07.026","volume":"73","author":"B Sangro","year":"2020","unstructured":"Sangro B, Melero I, Wadhawan S, Finn RS, Abou-Alfa GK, Cheng AL, et al. Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma. J Hepatol. 2020;73(6):1460\u20139.","journal-title":"J Hepatol"},{"issue":"37","key":"4726_CR18","doi-asserted-by":"publisher","first-page":"eadh0831","DOI":"10.1126\/sciadv.adh0831","volume":"9","author":"E Boslem","year":"2023","unstructured":"Boslem E, Reibe S, Carlessi R, Smeuninx B, Tegegne S, Egan CL, et al. Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC. Sci Adv. 2023;9(37):eadh0831.","journal-title":"Sci Adv"},{"issue":"11","key":"4726_CR19","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1097\/JS9.0000000000000119","volume":"109","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Liu J, Xu X. A commentary on \u2018Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: a retrospective cohort study\u2019 (Int J Surg 2022;105:106843). Int J Surg. 2023;109(11):3656\u20138.","journal-title":"Int J Surg"},{"issue":"1","key":"4726_CR20","doi-asserted-by":"publisher","first-page":"12870","DOI":"10.1038\/s41598-017-12834-1","volume":"7","author":"DS Bai","year":"2017","unstructured":"Bai DS, Zhang C, Chen P, Jin SJ, Jiang GQ. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma. Sci Rep. 2017;7(1):12870.","journal-title":"Sci Rep"},{"issue":"1","key":"4726_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41421-023-00563-x","volume":"9","author":"H He","year":"2023","unstructured":"He H, Chen S, Fan Z, Dong Y, Wang Y, Li S, et al. Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. Cell Discov. 2023;9(1):60.","journal-title":"Cell Discov"},{"issue":"8","key":"4726_CR22","first-page":"928","volume":"22","author":"J Xiang","year":"2025","unstructured":"Xiang J, Li Y, Mei S, Ou Z, Wang L, Ke Y, et al. Novel diagnostic and therapeutic strategies based on PANoptosis for hepatocellular carcinoma. Cancer Biol Med. 2025;22(8):928\u201339.","journal-title":"Cancer Biol Med"},{"key":"4726_CR23","doi-asserted-by":"publisher","first-page":"1519999","DOI":"10.3389\/fimmu.2024.1519999","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Liang YB, Wang QB, Li YK, Chen XM, Luo WL, et al. Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis. Front Immunol. 2025;15:1519999.","journal-title":"Front Immunol"},{"key":"4726_CR24","doi-asserted-by":"publisher","first-page":"110413","DOI":"10.1016\/j.biopha.2020.110413","volume":"129","author":"Y Chen","year":"2020","unstructured":"Chen Y, Fan Y, Guo DY, Xu B, Shi XY, Li JT, et al. Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells. Biomed Pharmacother. 2020;129:110413.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"4726_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamasurg.2018.4334","volume":"154","author":"XF Xu","year":"2019","unstructured":"Xu XF, Xing H, Han J, Li ZL, Lau WY, Zhou YH, et al. Risk Factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg. 2019;154(3):209\u201317.","journal-title":"JAMA Surg"},{"issue":"2","key":"4726_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7150\/thno.27654","volume":"9","author":"J Meng","year":"2019","unstructured":"Meng J, Ai X, Lei Y, Zhong W, Qian B, Qiao K, et al. USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma. Theranostics. 2019;9(2):573\u201387.","journal-title":"Theranostics"},{"issue":"1","key":"4726_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M. NF-\u03baB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2011;21(1):159\u201368.","journal-title":"Cell Res"},{"issue":"6","key":"4726_CR28","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.immuni.2021.04.027","volume":"54","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhangyuan G, Wang F, Jin K, Shen H, Zhang L, et al. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation. Immunity. 2021;54(6):1168\u2013e11858.","journal-title":"Immunity"},{"issue":"13","key":"4726_CR29","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1158\/1078-0432.CCR-18-3510","volume":"25","author":"Y Liu","year":"2019","unstructured":"Liu Y, Liu L, Zhou Y, Zhou P, Yan Q, Chen X, et al. CKLF1 Enhances inflammation-mediated carcinogenesis and prevents doxorubicin-induced apoptosis via IL6\/STAT3 signaling in HCC. Clin Cancer Res. 2019;25(13):4141\u201354.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4726_CR30","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/hep.23099","volume":"50","author":"J N\u00e9meth","year":"2009","unstructured":"N\u00e9meth J, Stein I, Haag D, Riehl A, Longerich T, Horwitz E, et al. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology. 2009;50(4):1251\u201362.","journal-title":"Hepatology"},{"key":"4726_CR31","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.2147\/JIR.S378099","volume":"15","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Guan R, Zou Y, Jian Z, Lin Y, Guo R, et al. Nomogram based on inflammatory biomarkers to predict the recurrence of hepatocellular carcinoma-a multicentre experience. J Inflamm Res. 2022;15:5089\u2013102.","journal-title":"J Inflamm Res"},{"issue":"8","key":"4726_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00262-024-03713-6","volume":"73","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Mei J, Guan R, Zhang J, Xiong X, Gan J, et al. A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapy. Cancer Immunol Immunother. 2024;73(8):158.","journal-title":"Cancer Immunol Immunother"},{"issue":"21","key":"4726_CR33","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E Trefts","year":"2017","unstructured":"Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol. 2017;27(21):R1147\u201351.","journal-title":"Curr Biol"},{"issue":"3","key":"4726_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.7150\/jca.79593","volume":"14","author":"VC Wong","year":"2023","unstructured":"Wong VC, Wong MI, Lee VH, Man K, Ng KT, Cheung TT. Prognostic MicroRNA fingerprints predict recurrence of early-stage hepatocellular carcinoma following hepatectomy. J Cancer. 2023;14(3):480\u20139.","journal-title":"J Cancer"},{"issue":"1","key":"4726_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/hbsn-19-870","volume":"11","author":"Y Mao","year":"2022","unstructured":"Mao Y, Wang J, Zhu Y, Chen J, Mao L, Kong W, et al. Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2022;11(1):13\u201324.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"6","key":"4726_CR36","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550\u20138.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4726_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","volume":"66","author":"DJ Pinato","year":"2017","unstructured":"Pinato DJ, Sharma R, Allara E, Yen C, Arizumi T, Kubota K, et al. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. J Hepatol. 2017;66(2):338\u201346.","journal-title":"J Hepatol"},{"issue":"7","key":"4726_CR38","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/bjc.2016.33","volume":"114","author":"H Toyoda","year":"2016","unstructured":"Toyoda H, Lai PB, O\u2019Beirne J, Chong CC, Berhane S, Reeves H, et al. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer. 2016;114(7):744\u201350.","journal-title":"Br J Cancer"},{"key":"4726_CR39","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"12","author":"WL Luo","year":"2025","unstructured":"Luo WL, Wang QB, Li YK, Liang YB, Li J, Chen XM, et al. Impact of middle hepatic vein resection during hemihepatectomy on surgical outcomes and long-term prognosis in hepatocellular carcinoma: a retrospective study. J Hepatocell Carcinoma. 2025;12:2681\u201392.","journal-title":"J Hepatocell Carcinoma"},{"key":"4726_CR40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2147\/JHC.S373960","volume":"9","author":"Y Shan","year":"2022","unstructured":"Shan Y, Yu X, Yang Y, Sun J, Wu S, Mao S, et al. Nomogram for the preoperative prediction of the macrotrabecular-massive subtype of hepatocellular carcinoma. J Hepatocell Carcinoma. 2022;9:717\u201328.","journal-title":"J Hepatocell Carcinoma"},{"issue":"6","key":"4726_CR41","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/jmri.29052","volume":"59","author":"J Cheng","year":"2024","unstructured":"Cheng J, Li X, Wang L, Chen F, Li Y, Zuo G, et al. Evaluation and prognostication of Gd-EOB-DTPA MRI and CT in patients with macrotrabecular-massive hepatocellular carcinoma. J Magn Reson Imaging. 2024;59(6):2071\u201381.","journal-title":"J Magn Reson Imaging"},{"key":"4726_CR42","doi-asserted-by":"publisher","first-page":"113634","DOI":"10.1016\/j.biopha.2022.113634","volume":"154","author":"AS Bhale","year":"2022","unstructured":"Bhale AS, Venkataraman K. Leveraging knowledge of HDLs major protein ApoA1: Structure, function, mutations, and potential therapeutics. Biomed Pharmacother. 2022;154:113634.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"4726_CR43","doi-asserted-by":"publisher","first-page":"pbad021","DOI":"10.1093\/pcmedi\/pbad021","volume":"6","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen S, Xiao X, Yang F, Wang J, Zong H, et al. Impact of apolipoprotein A1 on tumor immune microenvironment, clinical prognosis and genomic landscape in hepatocellular carcinoma. Precis Clin Med. 2023;6(3):pbad021.","journal-title":"Precis Clin Med"},{"key":"4726_CR44","doi-asserted-by":"publisher","first-page":"1626914","DOI":"10.3389\/fimmu.2025.1626914","volume":"16","author":"J Hu","year":"2025","unstructured":"Hu J, Liu Q, Ren Q, He W, Hou J, Wang X, et al. GOT2: a moonlighting enzyme at the crossroads of cancer metabolism and theranostics. Front Immunol. 2025;16:1626914.","journal-title":"Front Immunol"},{"issue":"18","key":"4726_CR45","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-22-0042","volume":"82","author":"Y Li","year":"2022","unstructured":"Li Y, Li B, Xu Y, Qian L, Xu T, Meng G, et al. GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors. Cancer Res. 2022;82(18):3223\u201335.","journal-title":"Cancer Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04726-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04726-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04726-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:01:53Z","timestamp":1774620113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04726-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4726"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04726-6","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patients prior to tissue sample collection, in accordance with the guidelines of the Declaration of Helsinki. No identifiable patient information was involved. The Institutional Ethics Committee of Nanjing Drum Tower Hospital approved this study (2013-081-12).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"495"}}